Genmab A/S (GMAB) |
|
36.61 -0.72 (-1.93%)
|
10-01 09:17 |
|
Open: |
36.37 |
Pre. Close: |
37.33 |
|
High:
|
36.92 |
Low:
|
36.08 |
|
Volume:
|
795,011 |
Market Cap:
|
23,694M |
|
|
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
37.737 - 37.889 |
37.889 - 38.045 |
|
Low:
|
36.567 - 36.725 |
36.725 - 36.887 |
|
Close:
|
37.111 - 37.385 |
37.385 - 37.668 |
|
Technical analysis |
as of: 2020-09-30 4:42:07 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 45.40 One year: 53.03 |
| Support: |
Support1: 35.87 Support2: 34.01 |
| Resistance: |
Resistance1: 38.87 Resistance2: 45.40 |
| Pivot: |
36.77 |
| Moving Average: |
MA(5): 36.28  MA(20): 36.59
MA(100): 33.96 MA(250): 26.94 |
| MACD: |
MACD(12,26): 0.13 Signal(9): 0.18 |
| Stochastic oscillator: |
%K(14,3): 55.80 %D(3): 43.56 |
| RSI: |
RSI(14): 53.65 |
| 52-week: |
High: 38.87 Low: 16.24 Change(%): 97.9 |
| Average Vol(K): |
3-Month: 61795 10-Days: 77959 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.GMAB has closed below upper band by 36.8%. Bollinger Bands are 12.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 29 Sep 2020
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewswire
Tue, 29 Sep 2020
Capital Increase in Genmab as a Result of Employee Warrant Exercise - globenewswire.com
Thu, 24 Sep 2020
Genmab A/S (NASDAQ:GMAB) Finding Zero Support - The Oracle Dispatch
Wed, 23 Sep 2020
Moderate Buy Genmab A/S [GMAB] Stock Before Shares Hit Major Turbulence - mzpnews.com
Tue, 22 Sep 2020
Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen - GlobeNewswire
Mon, 21 Sep 2020
Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020 - GlobeNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Neutral |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
652 |
| Shares Float (M) |
645 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
4.00 |
|
Shares Short (K)
|
970 |
|
Shares Short P. Month (K)
|
654 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
54.68 |
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
29.9 |
|
Return on Equity (ttm)
|
43.3 |
|
Qtrly Rev. Growth
|
604.3 |
|
Gross Profit (p.s.)
|
8.231 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
3874.10 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
2.35 |
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
